stella
beta
Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI) — Stella
Recruiting
Back to Peripheral Nerve Injury trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
University of Miami, Miami, Florida
View full record on ClinicalTrials.gov